10-(2-Benzoxazolcarbonyl)-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid: A potential inhibitor of GAR transformylase and AICAR transformylase

  • Thomas H. Marsilje
  • , Michael P. Hedrick
  • , Joel Desharnais
  • , Kevin Capps
  • , Ali Tavassoli
  • , Yan Zhang
  • , Ian A. Wilson
  • , Stephen J. Benkovic
  • , Dale L. Boger

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

The design and synthesis of 10-(2-benzoxazolcarbonyl)-DDACTHF (1) as an inhibitor of glycinamide ribonucleotide transformylase (GAR Tfase) and aminoimidazole carboxamide transformylase (AICAR Tfase) are reported. Ketone 1 and the corresponding alcohol 13 were evaluated for inhibition of GAR Tfase and AICAR Tfase and the former was found to be a potent inhibitor of recombinant human (rh) GAR Tfase (Ki=600 nM).

Original languageEnglish (US)
Pages (from-to)4503-4509
Number of pages7
JournalBioorganic and Medicinal Chemistry
Volume11
Issue number20
DOIs
StatePublished - Oct 1 2003

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Organic Chemistry
  • Clinical Biochemistry

Fingerprint

Dive into the research topics of '10-(2-Benzoxazolcarbonyl)-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid: A potential inhibitor of GAR transformylase and AICAR transformylase'. Together they form a unique fingerprint.

Cite this